meclizine has been researched along with Drug Withdrawal Symptoms in 2 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case of a patient who treated withdrawal symptoms from trans-dermal scopolamine with meclizine is reported." | 1.35 | Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine. ( Ezzo, DC; Patel, PN, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdhury, NA | 1 |
| Sewatsky, ML | 1 |
| Kim, H | 1 |
| Patel, PN | 1 |
| Ezzo, DC | 1 |
2 other studies available for meclizine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Topics: Adolescent; Antiemetics; Botulinum Toxins, Type A; Cerebral Palsy; Delayed Diagnosis; Humans; Inject | 2017 |
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
Topics: Administration, Cutaneous; Adult; Antiemetics; Female; Humans; Meclizine; Motion Sickness; Muscarini | 2009 |